Clinical Trial Update: Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of weekly paclitaxel in combination with neratinib and trastuzumab in metastatic HER2-positive breast cancer; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Neratinib (Nerlynx) (neratinib)
• Taxol (paclitaxel) (paclitaxel)
• Trastuzumab (Herceptin) (trastuzumab)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED